Vir Biotechnology, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2017 | — | — | $187.9M |
| Sep 2018 | — | — | $47.7M |
| Dec 2018 | $61.6M | $191.6M | $47.6M |
| Mar 2019 | — | — | $64.7M |
| Jun 2019 | — | — | $80.7M |
| Sep 2019 | $66.8M | $422.6M | $93.7M |
| Dec 2019 | $88.1M | $512.1M | $109.3M |
| Mar 2020 | $96.8M | $477.1M | $168.4M |
| Jun 2020 | $108.5M | $672.2M | $371.8M |
| Sep 2020 | $130.9M | $943.3M | $462.5M |
| Dec 2020 | $201.9M | $918.8M | $436.6M |
| Mar 2021 | $484.6M | $1.14B | $521.4M |
| Jun 2021 | $320.3M | $1.06B | $742.0M |
| Sep 2021 | $333.9M | $1.21B | $714.5M |
| Dec 2021 | $522.4M | $1.95B | $347.8M |
| Mar 2022 | $886.1M | $2.89B | $812.4M |
| Jun 2022 | $667.0M | $2.62B | $1.51B |
| Sep 2022 | $546.1M | $2.70B | $963.7M |
| Dec 2022 | $724.1M | $2.80B | $848.6M |
| Mar 2023 | $695.1M | $2.67B | $824.9M |
| Jun 2023 | $433.7M | $2.24B | $666.9M |
| Sep 2023 | $369.8M | $2.04B | $452.1M |
| Dec 2023 | $328.8M | $1.92B | $241.6M |
| Mar 2024 | $246.6M | $1.79B | $160.7M |
| Jun 2024 | $235.9M | $1.67B | $296.9M |
| Sep 2024 | $257.6M | $1.50B | $168.4M |
| Dec 2024 | $248.4M | $1.40B | $222.9M |
| Mar 2025 | $263.9M | $1.31B | $273.6M |
| Jun 2025 | $245.1M | $1.19B | $211.1M |
| Sep 2025 | $223.4M | $1.02B | $170.1M |
| Dec 2025 | $237.5M | $1.00B | $232.2M |
| Mar 2026 | $212.8M | $1.03B | $274.2M |
| Jun 2026 | $232.3M | $1.21B | $278.7M |